Deep Track Capital
LKFT icon

Deep Track Capital’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Deep Track Capital’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-741,068
Closed -$18.6M – 72
2025
Q1 		$18.6M Sell
741,068
-39,710
-5% -$1M 0.6% 40
2024
Q4 		$21.5M Buy
+780,778
New +$21.8M 0.8% 35

Other funds holding LKFT

Gilead Sciences
Gilead Sciences Foster City, California $1.46B AUM 71.23% 1-Year Est. Return
Tang Capital Management
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Madison Avenue Partners
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
Prosight Management
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EcoR1 Capital
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Segall Bryant & Hamill
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
DME Capital Management
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deep Track Capital's LKFT Position: Q2 2025 in Review

Deep Track Capital sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2025, closing a stake of 741,068 shares — an estimated $18.6M sold.

Deep Track Capital first reported a position in LKFT in Q4 2024 and held it in 2 quarters. The position peaked at $21.5M in Q4 2024. 85 funds tracked by Wall St. Rank hold LKFT as of Q2 2025.

  • Deep Track Capital reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2025 after selling out during the quarter.
  • Deep Track Capital sold 741,068 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2025, an estimated $18.6M.
  • Deep Track Capital first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2024 and held it in 2 quarters.
  • Deep Track Capital's Lakefront Biotherapeutics American Depositary Shares position peaked at $21.5M in Q4 2024.
  • 85 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2025.

Based on Deep Track Capital's 13F filing for Q2 2025, filed 14 Aug 2025.